Min Liu, Jonathan G. Faris, Amanda R. Panfil, Cody J. Warren. How new approach methods are reshaping virology research. Journal of Virology. 2026;100(4):e0132625. doi:10.1128/jvi.01326-25
Junyoung Kim, Xuening Zhang, Richard Wang, et al. Vascularized and Perfusable Human Heart-on-a-Chip Model Recapitulates Aspects of Myocardial Ischemia and Enables Analysis of Nanomedicine Delivery. Advanced Materials. 2025;37(41):e18909. doi:10.1002/adma.202418909
Jacintha Shenton, Imein Bousnina, Michael Oropallo, et al. Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment. Drug Discovery Today. 2025;30(4):104328. doi:10.1016/j.drudis.2025.104328
Decio L. Eizirik, Priscila L. Zimath. Diabetes research enters the biobank era: searching for the truth in a deep well. The Journal of Clinical Investigation. 2025;135(23):e199728. doi:10.1172/JCI199728
Eryn Slankster-Schmierer. Modernizing toxicology: The importance of accessible NAM training. Toxicology Letters. 2025;406:38-39. doi:10.1016/j.toxlet.2025.02.011
Melpomeni Platani, Hao Jiang, Lindsay Davidson, et al. Screening for variable drug responses using human iPSC cohorts. PloS One. 2025;20(5):e0323953. doi:10.1371/journal.pone.0323953
Maria T. Baltazar, Sophie Cable, Richard Cubberley, et al. Making safety decisions for a sunscreen active ingredient using next-generation risk assessment: Benzophenone-4 case study. ALTEX. 2025;42(3):511-530. doi:10.14573/altex.2501201
David Moher, Anna Catharina Vieira Armond. Publisher and journal reciprocity for peer review: Not so much. Accountability in Research. 2025;32(5):832-837. doi:10.1080/08989621.2025.2450451
Kang Zhang, Xin Yang, Yifei Wang, et al. Artificial intelligence in drug development. Nature Medicine. 2025;31(1):45-59. doi:10.1038/s41591-024-03434-4